Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Providers Support FDA Quest For Public Drug Manufacturing Quality Ratings

Feb 20 2020

• By Bowman Cox

Businessman pressing smiley face emoticon on virtual touch screen. Customer service evaluation concept. — ratings would improve drug quality, but when? • Source: Shutterstock

Related Content

FDA Quality Metrics Could Lead Market to Pay for Quality, Prevent Shortages, Woodcock Says

Feb 28 2013

Cleveland Clinic Drug Quality Dashboard Helps Guide Product Choices

Feb 20 2020

Drug Shortage Plan Would Grade Firms To Encourage High-Quality Production

Oct 30 2019

The FDA Builds On Lessons Learned In Rebuilding Quality Metrics Program

Dec 12 2019

How FDA Says Its KASA Plan Will Streamline Quality Reviews

Apr 10 2019

Civica Interested In Retired Or Withdrawn ANDAs

Jan 20 2020

Hikma And Civica Ship Eight Essential Injectables

Dec 10 2019

US FDA And OMB Should ‘Pause’ Billion-Dollar Quality Metrics Program, Industry Groups Say

Mar 30 2017

DeLauro Renews Push To Give FDA Mandatory Recall Authority For Drugs

Jan 12 2020

FDA Lauds St. Gallen's Findings On 10 Metrics For Ensuring Drug Quality

Jun 15 2018

White House Mulls Proposal To Pause FDA's Quality Metrics Initiative

Jun 23 2017

Additional Topics

United States Manufacturing Quality Generic Drugs BioPharmaceutical

More from Manufacturing

More from Compliance

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window